More Exclusive Features

Plant researchers discuss breeding priorities for stable hemp genetics

To maintain growth, the booming U.S. hemp industry needs a reliable supply of steady, stable seed genetics. Professional and academic plant breeders are rushing to fill the market demand, but it might take at least another five years to develop those genetics, according to longtime breeders. That’s because it takes time to breed, trial and […]

Read More

Ongoing hemp-transport questions trigger Minnesota warning

A Minnesota hemp industry group is warning manufacturers not to order hemp biomass from other states in the wake of a South Dakota drug arrest of a deliveryman bringing plants from Colorado to Minnesota for extraction. The Minnesota warning comes as a federal appeals court prepares to hear arguments next week over hemp transportation. “The ability […]

Read More

USDA: National THC test for hemp ‘as challenging as you think it is’

Federal agriculture authorities are struggling to craft a nationwide THC testing standard so that state and local regulators can tell hemp from marijuana, complicating the release of standardized production rules, according to an official with the U.S. Department of Agriculture (USDA). William Richmond, head of the Specialty Crops Program in the USDA’s Agricultural Marketing Service, […]

Read More

‘The FDA is struggling’: Former US surgeon general Carmona on government’s approach to CBD

The booming CBD industry is eagerly waiting to see if U.S. health regulators change course and start allowing cannabinoid treatments in food and dietary supplements. Many are hoping the U.S. Food and Drug Administration (USDA) will condone over-the-counter CBD products while setting production and purity standards to eliminate inferior CBD products from the market. Against […]

Read More

Chinese tariffs having minimal effects on US hemp industry, experts say

Most American farmers are in full-fledged panic mode after companies in China suspended their use of U.S. agricultural products in response to tariffs imposed by the Trump administration on Chinese goods. But the nascent U.S. hemp industry shouldn’t worry, economists and trade experts told Hemp Industry Daily. A $5.9 billion market, China is one of […]

Read More

Strong CBD drug release powers GW Pharmaceuticals’ record revenue

Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, a seizure control drug approved by the U.S. Food and Drug Administration, has seen brisk sales and new patient enrollments since the drug’s launch last November. GW Pharma (Nasdaq: GWPH) reported that […]

Read More